Markets:

Overview

News

Currencies

International

Treasuries

Canopy Growth Corporation - Common Shares (NQ:CGC)

0.5625 -0.0425 (-7.02%)

Delayed Quote Updated: 1:15 PM EST, Nov 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Canopy Growth Corporation - Common Shares

< Previous 1 2 3 4 5 6 7 8 9

...

79 80 Next >

Which of These 5 Cannabis Stocks Has the Strongest Balance Sheet? ↗

November 08, 2026

Debt and cash flow reveal some significant differences.

Via The Motley Fool

Topics Cannabis

Canopy Growth Corporation: 3 Key Takeaways for Long-Term Investors ↗

November 07, 2026

Canopy's EU GMP certification spans its entire supply chain, so it can sell into Europe without relying on third parties.

Via The Motley Fool

Topics Cannabis Earnings Economy

Canopy Growth (CGC) Q2 2027 Earnings Call Transcript ↗

November 06, 2026

Margins slipped as Canadian medical reimbursement fell, even as revenue climbed.

Via The Motley Fool

Topics Cannabis Earnings

Cannabis Stocks Are Splitting Into Profitable Leaders and Sentiment-Driven Laggards ↗

November 05, 2026

Via Chartmill

Topics Cannabis

Canopy Growth Q2 Earnings Call Highlights ↗

November 06, 2026

Canopy Growth (NASDAQ:CGC) reported a 22% increase in fiscal second-quarter revenue as international cannabis sales more than doubled, and executives said the company remains on track to achieve...

Via MarketBeat

Topics Cannabis Earnings

Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in Cannabis ↗

October 30, 2026

Tilray commands a 4x revenue advantage, but Canopy's latest quarter hints at momentum—here's what the data reveals about their competitive positioning.

Via The Motley Fool

Topics Cannabis Economy

Canopy Growth Shareholders Approve Reverse Split Authority, Elect Board ↗

October 23, 2026

Canopy Growth (NASDAQ:CGC) shareholders approved all matters presented at the company’s reconvened 2026 Annual General and Special Meeting, including a share-consolidation authorization, the election...

Via MarketBeat

Topics Cannabis

Trump's Marijuana Order Is Stuck at the DEA. Here's What That Means for Canopy Growth. ↗

October 18, 2026

Larger issues loom at home for the Canada-based cannabis company.

Via The Motley Fool

Topics Cannabis Government

Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026? ↗

October 15, 2026

The cannabis industry is still finding its footing, but Tilray just posted record revenue with its beverage business turning profitable. Canopy is narrowing losses and targeting positive EBITDA by...

Via The Motley Fool

Topics Cannabis

Canopy Growth vs. Tilray Brands: Which Healthcare Stock Is a Better Buy in 2026? ↗

October 10, 2026

Canopy pursues a lean U.S.-focused strategy while Tilray has diversified into beverages, but their diverging paths and financial profiles reveal starkly different risk-reward profiles for 2026.

Via The Motley Fool

Topics Cannabis

Can Canopy Growth Survive Another 5 Years? ↗

October 06, 2026

The company is still burning through cash, and its outlook doesn't look all that great.

Via The Motley Fool

Topics Cannabis

Canopy Growth Is Closing in on Positive EBITDA. Should You Buy the Stock? ↗

September 30, 2026

Improving fundamentals are making Canopy harder to ignore.

Via The Motley Fool

Topics Cannabis

Canopy Growth Is Eyeing Another Reverse Stock Split. Will It Be Enough to Light a Fire Beneath the Beaten-Down Pot Stock? ↗

September 23, 2026

Canopy Growth's stock has continued to fall, prompting the company to proactively seek to retain access to capital markets.

Via The Motley Fool

Topics Bonds Cannabis

Canopy Growth's Business Is Improving. So Why Isn't the Stock Performing Better? ↗

September 14, 2026

Two long-standing issues continue to weigh on this cannabis stock.

Via The Motley Fool

Topics Cannabis

Canopy Growth's Revenue Grew 13% Last Quarter. Investors Barely Reacted. Here's Why. ↗

September 07, 2026

Revenue is growing, but the cannabis company still has a lot to prove to investors.

Via The Motley Fool

Topics Cannabis

Should You Buy Canopy Growth Stock on the Rebound? ↗

September 05, 2026

Canopy Growth benefited from growth across all its divisions in the first quarter of fiscal 2027, but does that make it a worthwhile investment?

Via The Motley Fool

Topics Cannabis

Better Cannabis Stock to Buy Right Now: Canopy Growth or Tilray Brands? ↗

September 02, 2026

The Canadian cannabis companies are both seeing strong growth, but one is a better buy right now.

Via The Motley Fool

Topics Cannabis

Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners. ↗

August 21, 2026

After a huge gold rush, the marijuana sector stumbled, and now consolidation is gaining momentum.

Via The Motley Fool

Topics Cannabis

Curaleaf Wants to Buy Aurora Cannabis for $272 Million. Is Canopy Growth the Next Marijuana Takeover Target? ↗

August 16, 2026

Cannabis consolidation appears to be accelerating.

Via The Motley Fool

Topics Cannabis

Canopy Growth (CGC) Q1 2027 Earnings Call Transcript ↗

August 14, 2026

Revenue grew 13% as MTL integration and Polish market strength drove results.

Via The Motley Fool

Topics Cannabis Earnings World Trade

Will Canopy Growth Get Acquired? ↗

August 13, 2026

Curaleaf is attempting to acquire Canopy Growth's rival, Aurora Cannabis, and there could be more consolidation to come in the industry.

Via The Motley Fool

Topics Cannabis

Canopy Growth Targets European Cannabis Expansion After MTL Deal and Cost Cuts ↗

August 12, 2026

Canopy Growth (NASDAQ:CGC) is positioning itself for further expansion in medical cannabis, European markets and Canadian recreational cannabis after restructuring operations, reducing costs and...

Via MarketBeat

Topics Cannabis Economy

Canopy Growth: Penny Stock Purgatory -- or Cannabis Rebound in the Making? ↗

August 11, 2026

The turnaround is becoming more believable.

Via The Motley Fool

Topics Cannabis

Why Rescheduling Might Not Move Canopy Growth's Stock as Much as You Think ↗

August 08, 2026

Canopy Growth is a marijuana stock, but U.S. regulations aren't the main driver of its business.

Via The Motley Fool

Topics Cannabis

Canopy Growth Q1 Earnings Call Highlights ↗

August 07, 2026

Canopy Growth (NASDAQ:CGC) reported first-quarter fiscal 2027 net revenue of C$81.2 million, up 13% from the prior-year period, as the company recorded year-over-year growth across its cannabis and...

Via MarketBeat

Topics Cannabis Earnings

Thinking About Buying Canopy Growth? You May Want to Wait for This 1 Thing to Happen First. ↗

July 25, 2026

The next key catalyst for this cannabis stock lies in the hands of a U.S. Federal Government agency.

Via The Motley Fool

Topics Cannabis Economy Government

President Trump's Major Marijuana Move: What It Means for Canopy Growth, Green Thumb, and Tilray ↗

July 17, 2026

The president directed federal authorities to reschedule medical marijuana.

Via The Motley Fool

Topics Cannabis Government

Is Canopy Growth Stock Finally Worth Buying After Losing 99% of Its Value? ↗

July 08, 2026

A lower stock price doesn't eliminate investment risk.

Via The Motley Fool

Topics Cannabis

Canopy Growth: Is Another Reverse Stock Split Inevitable? ↗

July 07, 2026

Shares of the cannabis company have fallen below the $1 mark again.

Via The Motley Fool

Topics Cannabis

Could Canopy Growth Stock Deliver a 4X Gain? 1 Analyst Thinks So. ↗

July 04, 2026

Be careful before bucking the bearish trend.

Via The Motley Fool

Topics Cannabis

< Previous 1 2 3 4 5 6 7 8 9

...

79 80 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.